Effect of polymorphism on IL1A to cancer susceptibility: Evidence based on 34,016 subjects

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69:7–34.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281:8–27.
   PubMed Web of Science ®Google Scholar
• Malik A, Kanneganti TD. Function and regulation of IL-1α in inflammatory diseases and cancer. Immunol Rev. 2018;281:124–137.
   PubMed Web of Science ®Google Scholar
• Kuan EL, Ziegler SF. A tumor-myeloid cell axis, mediated via the cytokines IL-1alpha and TSLP, promotes the progression of breast cancer. Nat Immunol. 2018;19:366–374.
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Sawai H, Ma J, et al. IL-1alpha secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1alpha release and tumor cells' potential for liver metastasis. J Surg Oncol. 2009;99:361–367.
   PubMed Web of Science ®Google Scholar
• Seddighzadeh M, Larsson P, Ulfgren AC, et al. Low IL-1alpha expression in bladder cancer tissue and survival. Eur Urol. 2003;43:362–368.
   PubMed Web of Science ®Google Scholar
• Song Z, Lin Y, Ye X, et al. Expression of IL-1alpha and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer. Med Sci Monit. 2016;22:4475–4481.
   PubMed Web of Science ®Google Scholar
• Sorrentino R, Terlizzi M, Di Crescenzo VG, et al. Human lung cancer-derived immunosuppressive plasmacytoid dendritic cells release IL-1alpha in an AIM2 inflammasome-dependent manner. The American Journal of Pathology. 2015;185:3115–3124.
   PubMed Web of Science ®Google Scholar
• Xu D, Matsuo Y, Ma J, et al. Cancer cell-derived IL-1alpha promotes HGF secretion by stromal cells and enhances metastatic potential in pancreatic cancer cells. J Surg Oncol. 2010;102:469–477.
   PubMed Web of Science ®Google Scholar
• Schmidt SV, Seibert S, Walch-Ruckheim B, et al. RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1alpha release, and efficient paracrine dendritic cell activation. Oncotarget 2015;6:8635–8647.
   PubMedGoogle Scholar
• Ma J, Sun X, Guo T, et al. Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1alpha/PI3K/NF-kappabeta pathway in human colon cancer cell. Cmar. 2017;Volume 9:481–493.
   Web of Science ®Google Scholar
• Cheng J, Li L, Liu Y, et al. Interleukin-1alpha induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells. Molecular Medicine Reports. 2012;6:955–960.
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Tochimoto A, Hara M, et al. Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1alpha and its transcription activity. Immunogenetics 2007;59:441–448.
   PubMed Web of Science ®Google Scholar
• McDowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis and rheumatism 1995;38:221–228.
   Google Scholar
• Dominici R, Cattaneo M, Malferrari G, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 2002;54:82–86.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–1012.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;1;127:820–826.
   Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute. 1959;22:719–748.
   PubMed Web of Science ®Google Scholar
• Eaton KD, Romine PE, Goodman GE, et al. Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility. Journal of Thoracic Oncology: official Publication of the International Association for the Study of Lung Cancer. 2018;13:649–659.
   PubMed Web of Science ®Google Scholar
• Sousa H, Mesquita L, Ribeiro J, et al. Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal. Immunobiology 2016;221:145–152.
   PubMed Web of Science ®Google Scholar
• Zidi S, Sghaier I, Zouidi F, et al. Interleukin-1 Gene Cluster Polymorphisms and its Haplotypes may Predict the Risk to Develop Cervical Cancer in Tunisia. Pathol Oncol Res. 2015;21:1101–1107.
   PubMed Web of Science ®Google Scholar
• Bushley AW, Ferrell R, McDuffie K, et al. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol. 2004;95:672–679.
   PubMed Web of Science ®Google Scholar
• Ai L, Shu Y. Association between interleukin- 1A polymorphisms and risk of glimoa. Chinese Journal of Laboratory Diagnosis 2014;18:1446–1448.
   Google Scholar
• Zheng L, Yin J, Wang L, et al. Interleukin 1B rs16944 G > A polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. Clinical Biochemistry. 2013;46:1469–1473.
   PubMed Web of Science ®Google Scholar
• Hoeft B, Becker N, Deeg E, et al. Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma. Cancer Causes Control. 2008;19:163–173.
   PubMed Web of Science ®Google Scholar
• Saenz-Lopez P, Carretero R, Cozar JM, et al. Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer. BMC Cancer. 2008;8:382.
   PubMed Web of Science ®Google Scholar
• Ennas MG, Moore PS, Zucca M, et al. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol. 2008;26:98–103.
   PubMed Web of Science ®Google Scholar
• Hou L, El-Omar EM, Chen J, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007;28:118–123.
   PubMed Web of Science ®Google Scholar
• Abazis-Stamboulieh D, Oikonomou P, Papadoulis N, et al. Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma. Leuk Lymphoma. 2007;48:2196–2203.
   PubMed Web of Science ®Google Scholar
• Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. The Lancet Oncology 2006; Jan7:27–38.
   PubMed Web of Science ®Google Scholar
• Grimm C, Berger I, Tomovski C, et al. A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis. Gynecologic Oncology. 2004;92:936–940.
   PubMed Web of Science ®Google Scholar
• Foster CB, Lehrnbecher T, Samuels S, et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000; Oct 196:2562–2567.
   PubMed Web of Science ®Google Scholar
• Bai L, Yu H, Wang H, et al. Genetic single-nucleotide polymorphisms of inflammation-related factors associated with risk of lung cancer. Med Oncol. 2013;30:414.
   PubMed Web of Science ®Google Scholar
• Yang ZH, Dai Q, Zhong L, et al. Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma. Mol Carcinog. 2011;50:208–214.
   PubMed Web of Science ®Google Scholar
• Qu YL, Yu H, Chen YZ, et al. Relationships between genetic polymorphisms in inflammation-related factor gene and the pathogenesis of nasopharyngeal cancer. Tumor Biol. 2014;35:9411–9418.
   PubMed Web of Science ®Google Scholar
• Senguven B, Oygur T. Investigation of interleukin-1 alpha and interleukin-6 expression and interleukin-1 alpha gene polymorphism in keratocystic odontogenic tumors and ameloblastomas. Med Oral. 2011;16:e467–72.
   Google Scholar
• Eshghyar N, Nikbin B, Amirzargar A, et al. Gene polymorphism of interleukin-1 alpha and beta in keratocystic odontogenic tumors. Journal of Oral Pathology & Medicine: official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2012;41:697–701.
   PubMed Web of Science ®Google Scholar
• Snoussi K, Strosberg AD, Bouaouina N, et al. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. European Cytokine Network 2005; Dec16:253–260.
   PubMed Web of Science ®Google Scholar
• Hefler LA, Grimm C, Lantzsch T, et al. Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2005;11:5718–5721.
   PubMed Web of Science ®Google Scholar
• Wang HM. Relationship between interleukin- 1 gene cluster gene polymorphisms and susceptibility to cervical cancer : Dalian Medical University; 2005.
   Google Scholar
• Ioana Braicu E, Mustea A, Toliat MR, et al. Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients. Gynecol Oncol. 2007;104:680–685.
   PubMed Web of Science ®Google Scholar
• Liao H, Zhang L, Chen P, et al. Insertion/Deletion Polymorphism of IL1A 3'- UTR Associated with the Susceptibility of Prostate Cancer. Journal of Sichuan University (Medical Science Education) 2014; 45: 956–959.
   Google Scholar
• Ma Q, Mao Z, Du J, et al. Association between an insertion/deletion polymorphism in the interleukin-1alpha gene and the risk of colorectal cancer in a Chinese population. The International Journal of Biological Markers. 2018;33:401–406.
   Web of Science ®Google Scholar
• Hashemi M, Bahari G, Sarhadi S, et al. 4-bp insertion/deletion (rs3783553) polymorphism within the 3'UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population. J Cell Biochem. 2018;119:2627–2635.
   PubMed Web of Science ®Google Scholar
• Zhang J, Shi H, Xue M, et al. An insertion/deletion polymorphism in the interleukin-1A 3'untranslated region confers risk for gastric cancer. Cbm. 2016;16:359–365.
   Web of Science ®Google Scholar
• Yu X, Zhou B, Zhang Z, et al. Insertion/deletion polymorphism in IL1A 3'-UTR is associated with susceptibility to endometrial cancer in Chinese Han women. J Obstet Gynaecol Res. 2016;42:983–989.
   PubMed Web of Science ®Google Scholar
• Huang X, Yang Y, Cui ZW, et al. A functional insertion/deletion polymorphism in the IL1A gene is associated with decreased risk of breast cancer. Genet Mol Res. 2016;15: gmr7486.
   Web of Science ®Google Scholar
• Yan H, Sun R, Pan X, et al. Lack of association between an insertion/deletion polymorphism in IL1A and risk of colorectal cancer. Genet Mol Res. 2015;14:8490–8495.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sturgis EM, Sun Y, et al. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer. Eur J Cancer. 2015;51:1415–1423.
   PubMed Web of Science ®Google Scholar
• Huang J, Ni S, Li D, et al. An insertion/deletion polymorphism at miRNA-122 binding site in the IL1A is associated with a reduced risk of cervical squamous cell carcinoma. Genet Test Mol Biomarkers. 2015;19:331–334.
   PubMed Web of Science ®Google Scholar
• Du Y, Han X, Pu R, et al. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Front Med. 2014;8:217–226.
   PubMed Web of Science ®Google Scholar
• Pu Y, Zhang Z, Zhou B, et al. Association of an insertion/deletion polymorphism in IL1A 3'-UTR with risk for cervical carcinoma in Chinese Han Women. Hum Immunol. 2014;75:740–744.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhou B, Gao Q, et al. A polymorphism at miRNA-122-binding site in the IL-1alpha 3'UTR is associated with risk of epithelial ovarian cancer. Familial Cancer. 2014;13:595–601.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhu X, Li Z, et al. Association between a functional insertion/deletion polymorphism in IL1A gene and risk of papillary thyroid carcinoma. Tumor Biol. 2014;35:3861–3865.
   PubMedGoogle Scholar
• Zeng XF, Li J, Li SB. A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer. Tumor Biol. 2014;35:265–268.
   PubMed Web of Science ®Google Scholar
• Sima XT, Liu H, Yang YW, et al. Association between an insertion/deletion polymorphism at miRNA- 122 binding site in the 3' untranslated region of interleukin- 1A and risk of glioma Chinese. Journal of Cancer Prevention and Treatment 2013;20:580–582.
   Google Scholar
• He Y. Screening and Functional Analysis of Polymorphisms Residing in the MicroRNA Binding Sites of Hepatocellular Carcinoma- related Genes. Soochow University. 2010.
   Google Scholar
• Gao Y, He Y, Ding J, et al. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 2009;30:2064–2069.
   PubMed Web of Science ®Google Scholar
• Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994;19:382–384.
   PubMed Web of Science ®Google Scholar
• Bailly S, Fay M, Israel N, et al. The transcription factor AP-1 binds to the human interleukin 1 alpha promoter. Eur Cytokine Netw. 1996; Apr-Jun7:125–128.
   PubMed Web of Science ®Google Scholar
• McDowell TL, Symons JA, Duff GW. Human interleukin-1 alpha gene expression is regulated by Sp1 and a transcriptional repressor. Cytokine 2005;30:141–153.
   PubMed Web of Science ®Google Scholar
• Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Science Signaling. 2010;3:cm1.
   PubMed Web of Science ®Google Scholar
• Feldmeyer L, Werner S, French LE, et al. Interleukin-1, inflammasomes and the skin. Eur J Cell Biol. 2010;89:638–644.
   PubMed Web of Science ®Google Scholar
• Voronov E, Weinstein Y, Benharroch D, et al. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression. Cancer Research 1999; Mar 159:1029–1035.
   PubMed Web of Science ®Google Scholar
• Wu M, Jolicoeur N, Li Z, et al. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 2008;29:1710–1716.
   PubMed Web of Science ®Google Scholar
• Yu Z, Li Z, Jolicoeur N, et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Research. 2007;35:4535–4541.
   PubMed Web of Science ®Google Scholar